Cargando…
Distal Bile Duct Cancer: Radical (R0 > 1 mm) Resection Achieves Favorable Survival
Evaluation of the outcome after resection for distal bile duct cancer (DBC) with focus on the impact of microscopic histopathological resection status R0 (>1 mm) versus R1 (≤1 mm) vs R1 (direct). SUMMARY BACKGROUND DATA: DBC is a rare disease for which oncologic resection offers the only chance o...
Autores principales: | Tjaden, Christine, Hinz, Ulf, Klaiber, Ulla, Heger, Ulrike, Springfeld, Christoph, Goeppert, Benjamin, Schmidt, Thomas, Mehrabi, Arianeb, Strobel, Oliver, Berchtold, Christoph, Schneider, Martin, Diener, Markus, Neoptolemos, John P., Hackert, Thilo, Büchler, Markus W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762700/ https://www.ncbi.nlm.nih.gov/pubmed/34171863 http://dx.doi.org/10.1097/SLA.0000000000005012 |
Ejemplares similares
-
Protocol of a prospective, monocentric phase I/II feasibility study investigating the safety of multimodality treatment with a combination of intraoperative chemotherapy and surgical resection in locally confined or borderline resectable pancreatic cancer: the combiCaRe study
por: Roth, Susanne, et al.
Publicado: (2019) -
Cavernous transformation of the portal vein in pancreatic cancer surgery—venous bypass graft first
por: Schmidt, Thomas, et al.
Publicado: (2020) -
Protocol of a randomised controlled phase II clinical trial investigating PREoperative endoscopic injection of BOTulinum toxin into the sphincter of Oddi to reduce bile leakage after hepatic resection: the PREBOT-II trial
por: Mack, Claudia Eva, et al.
Publicado: (2023) -
Effects of neoadjuvant FOLFIRINOX and gemcitabine-based chemotherapy on cancer cell survival and death in patients with pancreatic ductal adenocarcinoma
por: Xie, Li, et al.
Publicado: (2019) -
Completion Pancreatectomy After Pancreatoduodenectomy: Who Needs It?
por: Loos, Martin, et al.
Publicado: (2023)